Please try another search
Biomm S.A. operates as a biotechnology company in Brazil. It offers AFREZZA, a human insulin inhalation powder; GHEMAXAN, an enoxaparina sodica; GLARGILIN, a glargine insulin; WOSULIN R, a human insulin; WOSULIN N, an isophane insulin; HERZUMA, a trastuzumab; and CANETA LIFEPEN G PARA APLICACAO DE INSULINA. The company was founded in 2001 and is headquartered in Nova Lima, Brazil.
Name | Age | Since | Title |
---|---|---|---|
Ítalo Aurélio Gaetani | - | 2013 | Director |
Luiz Francisco Novelli Viana | 74 | 2013 | Director |
Claudio Luiz Lottenberg | - | 2018 | Chairman of the Board |
Walfrido Silvino dos Mares Guia Neto | - | 2013 | Director |
Andre Capistrano Emrich | - | 2021 | Director |
Pedro Miguel Cordeiro Mateo | - | 2020 | Alternate Director |
Anna Emilia Sousa Leite Gaetani | - | 2020 | Alternate Director |
Frederico Martins Dos Mares Guia | - | 2020 | Alternate Director |
Bruno Rezende Bottrel Ricardo | - | 2024 | Alternate Director |
Pedro Augusto Mesquita Prado | - | 2024 | Director |
Geraldo Bernardes Franco de Moura | - | 2024 | Alternate Director |
David Khattar | - | 2024 | Alternate Director |
Marcio Pochmann | - | 2024 | Director |
Paulo K. Zuffo | 55 | 2024 | Alternate Director |
Laura Gomes Castanheira | - | 2024 | Director |
Rodrigo Godoi Rincon | - | 2024 | Alternate Director |
Eduardo A. Buarque de Almeida | 85 | - | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review